Resmed (RMD) Receivables - Net (2010 - 2026)

Resmed (RMD) has 17 years of Receivables - Net data on file, last reported at $998.8 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 10.03% year-over-year to $998.8 million; the trailing twelve-month figure through Mar 2026 stood at $998.8 million (up 10.03% YoY), and the FY2025 full-year result was $939.5 million, up 12.21% from the prior year.
• Receivables - Net for Q1 2026 stood at $998.8 million, up from $985.6 million in the prior quarter.
• Across five years, Receivables - Net topped out at $998.8 million in Q1 2026 and bottomed at $508.6 million in Q1 2022.
• The 5-year median for Receivables - Net is $779.3 million (2024), against an average of $777.5 million.
• The widest annual swing landed in 2022, when Receivables - Net retreated 6.24%; it then soared 34.94% in 2023.
• A 5-year view of Receivables - Net shows it stood at $672.3 million in 2022, then gained by 8.55% to $729.7 million in 2023, then increased by 17.84% to $859.9 million in 2024, then gained by 14.62% to $985.6 million in 2025, then gained by 1.34% to $998.8 million in 2026.
• The last three Receivables - Net figures came in at $998.8 million (Q1 2026), $985.6 million (Q4 2025), and $907.3 million (Q3 2025), per Business Quant data.

Peer Comparison